700 women followed for over a decade to see which fibroid treatments last longest
NCT ID NCT06430320
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows about 700 women for up to 12 years after they had a uterine-sparing fibroid treatment, such as myomectomy or uterine artery embolization. Researchers want to see how long these treatments last before another procedure is needed, and how women's symptoms and quality of life change over time. Participants were previously enrolled in the COMPARE-UF or ULTRA studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors and patients choose the best fibroid treatment by showing which ones last longest without needing another procedure.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results depend on participants accurately reporting their health over many years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE FIBROIDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henry Ford Health
Detroit, Michigan, 48202, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27514, United States
-
University of California San Francisco
San Francisco, California, 94143, United States